UMCU
- Address
- Heidelberglaan 100, 3584 CX Utrecht, The Netherlands
UMCU - Advanced Hematology and Cerebrovascular Research
The University Medical Center Utrecht (UMCU) is a leading academic medical center conducting cutting-edge clinical research in critical areas of hematologic malignancies and cerebrovascular disease. The center demonstrates expertise in phase III randomized controlled trials that address significant gaps in treatment protocols for life-threatening conditions.
- Acute myeloid leukemia and myelodysplastic syndromes with novel targeted therapies including venetoclax combinations
- Intracerebral hemorrhage management and secondary prevention strategies
- Antiplatelet therapy optimization for stroke survivors
UMCU's research portfolio reflects a commitment to evidence-based medicine through large-scale international trials. In hematologic oncology, the center investigates innovative induction and consolidation chemotherapy regimens for newly diagnosed patients with acute myeloid leukemia. Simultaneously, their cerebrovascular research program focuses on optimizing antiplatelet therapy in high-risk populations, particularly survivors of intracerebral hemorrhage, addressing the complex balance between preventing recurrent ischemic events and minimizing bleeding risk in vulnerable patient populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 9 therapeutic areas and 7 of 8 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
- 1Amsterdam UMC Stichting1active
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 271 other sites in The Netherlands
Therapeutic Area Benchmark — The Netherlands
Select a therapeutic area to compare against other sites in The Netherlands.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: The Netherlands
Market Share
Country: The Netherlands
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in UMCU
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Corticosteroid Injections for the Treatment of Achilles Tendinopathy: A Clinical Study | Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) | Phase III | Recruiting | Jun 2026 | — |
IMP list
lock Showing 1 of 8 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acetylsalicylic Acid | 1 | Unknown | 2025-10-07 | 2025-10-07 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.